Skip to main content

Epigenetics Communications

New Content Item (1)

Featured Collection - CLEPIC 2025: Advances in Epigenetics, with a Focus on Clinical Progresses, Applied Technologies and Epitarget Therapeutics

Clinical Epigenetics and Epigenetics Communications are proud to publish the extended proceedings of CLEPIC 2025, an international conference covering the latest developments in the expansive field of epigenetics.

CLEPIC

CLEPIC Logo

Save the Date for 

Clinical Epigenetics International Conference - CLEPIC 2026Barcelona, Spain, June 10 – 12, 2026

More information will be available at the conference website, as the event approaches: https://www.clepic.org


Welcoming words from Lucia Altucci and Marianne Rots, Editors in Chief of Clinical Epigenetics:

The need to meet and greet

Scientists need to meet to stay up-to-date within and beyond one’s own research field, to exchange and fuel new ideas, to keep inspired and to inspire others. We aim to offer you such platform by bringing together the editors, authors and readers of Clinical Epigenetics as well as the newly launched Epigenetics Communications. Moreover, we will invite industrial partners and public bodies, with a focus on training the next generation of multidisciplinary multi-epiomics scientists. This annual conference is devoted to fully exploiting the many applications of epigenetics in health and disease as well as in all kingdoms of life (biotech, crop breeding, etc.).

Looking forward to meeting and greeting many of you in a relaxed atmosphere full of state-of-the-art epigenetics!

Featured Articles

Meeting report on the round table discussions ‘epigenetics and society’ CLEPIC24
By Michelle GJL Habets, Marianne G Rots & Luca Chiapperino

At CLEPIC 2023 and 2024, round table discussions brought together natural and social scientists to reflect on the societal dimensions of epigenetic research. These sessions, now a regular fixture in the CLEPIC program, foster critical awareness, cross-disciplinary exchange, and a deeper understanding of how epigenetic knowledge is shaped and applied. Read the full report here.
Read full report here.


Bridging bioengineering and epigenetics: from technical innovations to clinical applications
By Jim Jacob, Quint C. van Loosen, Anna C. H. van den Berg van Saparoea, Federica Sarno & Pernette J. Verschure
This Meeting Report from the 7th International Conference on Epigenetics & Bioengineering held in Amsterdam, The Netherlands, highlights the outstanding research presented and the engaging discussions that took place.

Read full report here.

New Content Item

Call for Papers: Ecological Epigenetics: Unveiling Urban Impacts on the Epigenome

Epigenetics Communications is calling for submissions to our Collection on Ecological Epigenetics: Unveiling Urban Impacts on the Epigenome. This Collection will explore the ramifications of pollution on the epigenome with respect to long-term population health.

New Content Item

Call for Papers: Demonstrations of Transgenerational Epigenetic Inheritance in Various Model Systems

Epigenetics Communications is calling for submissions to our Collection on Demonstrations of Transgenerational Epigenetic Inheritance in Various Model Systems. This Collection aims to shed light on the mechanisms underlying transgenerational epigenetic inheritance and explore its potential evolutionary implications by presenting empirical evidence from diverse model systems.

Find Best-Fit Journal for your article!

Choosing the right journal is essential for every author, and we are fully committed to collaborating across our prestigious epigenetics journals to assist you in this process. To facilitate an informed decision, we offer a concise overview of our three journals. For more detailed information on each one, simply click on the journal title below: 

New Content Item•Clinical Epigenetics

•Epigenetics & Chromatin 

•Epigenetics Communications

Our dedicated Editors, with their extensive expertise in the field, will carefully evaluate your submission. If they believe that another journal within our network may better align with your research, they will propose a transfer during the peer-review process. This transfer will significantly expedite the handling of your submission, eliminating the need for additional peer-review rounds. We value your research and are here to support you every step of the way. Explore our options and make the most of our collaborative efforts to ensure your work reaches its full potential. 

Most recent articles RSS

View all articles

Most accessed articles RSS

View all articles

Collections

Editorial Policy Regarding Submissions describing “Negative Outcome Studies”

Provided that the methodology is consistent and sound, and the research question brings added value to the field, we warmly welcome ‘negative results’ studies. Manuscripts to be considered include, but are not limited to, descriptions of:

  • (failed) attempts to reproduce previously published data
  • irreproducible data between two (collaborating) laboratories
  • failed, but technically solid, attempts to prove a scientific hypothesis

Manuscripts which will not be considered include:

  • bioinformatic analyses without a solid statistical approach
  • "stand alone" bioinformatic analyses without experimental proof

Editorial Policy Regarding Submissions Focusing on Non-coding RNAs or RNA Modifications

Since epigenetic regulation and associated aspects of transcription regulation are wide-spread and complex, Epigenetics Communications aims to focus on those aspects of ncRNA-induced epigenetic regulation that concern changes in chromatin organization. As such manuscripts on non-coding RNAs or RNA modifications are only acceptable for the journal when including: 

  • data on the molecular epigenetic regulation of the expression of non-coding RNA (or its modifying enzymes) or
  • insights on the mechanism of action of the non-coding RNA on the chromatin and/or functioning of the DNA or
  • insights in mitotic stability of the RNA-induced effect

Editorial Policy Regarding Submissions Focusing on In silico research

Manuscripts reporting on straightforward bioinformatic analyses of publicly accessible databases only, cannot be considered for publication in Epigenetics Communications, unless the manuscript presents:

  • new, convincingly-described, scientific insights which will impact the field and/or
  • additional insights into underlying biological mechanisms (“wet-lab” validations) and/or
  • validations of findings in a replication cohort

Aims and scope

Epigenetics Communications covers the broad spectrum of epigenetic science from basic research to technological, molecular and preclinical innovations, as well as their theoretical, ethical and societal dimensions. Epigenetics Communications is an open-access journal devoted to the study and problematization of epigenetic principles and mechanisms in basic and translational research settings.

The editorial process of Epigenetics Communications focusses on the technical quality of the manuscript including the robustness and validity of the research, from methodological, analytical, statistical and ethical perspectives. Novelty and potential impact are not a pre-requisite for the evaluation.

It is also a forum for interdisciplinary debates around epigenetics, as well as for the investigation of its societal dimensions. In support of open science initiatives, the journal will have a level 4 data policy requiring data be made fully publicly available. The journal publishes studies related to the following topics:
 

  • Molecular Epigenetics (Histone Modifications; DNA Methylation; DNA Demethylation)
  • Nuclear Organization
  • Mitotic & Meiotic Heritability
  •  Epigenetic Drugs
  • Epigenetic Technologies
  • Epigenetic Bioengineering
  • Network Epigenetics
  • Computational Epigenomics
  • Single Cell Epigenetics
  • Epigenetic Toxicology
  •  Epigenetic studies using Model Organisms (Vertebrates; Invertebrates; Plants; Unicellular systems)
  • Epigenetics, Ethics and Society


Submissions describing clinical applications should first be considered for submission to the sister journal,  Clinical Epigenetics.

This innovative journal will also act as a forum to showcase and discuss alternative conclusions/interpretations of well-established epigenetic phenomena. These can be based either on the (re-)analyses of published and/or new data, or on the findings and results of epigenetic research in interaction with other disciplines. As such, we welcome 'systematic’ and ‘critical’ studies, be them positive (expected) or negative (non-expected) with respect to their outcomes.

Submit manuscript

Affiliated with

  • New Content Item

  • Epigenetics Communications is affiliated with the International Society for Molecular and Clinical Epigenetics (isMOCLEP). isMOCLEP is open to all those interested in the wide spectrum of epigenetic research, from molecular to clinical aspects. isMOCLEP community welcomes academic researchers, early career scientists, companies, policy makers, and beyond.

Annual Journal Metrics

Speed 
Submission to first editorial decision (median days): 10
Submission to acceptance (median days): 115

Usage 2024
Downloads: 41,008
Altmetric mentions: 15

Epigenetics Communications

ISSN: 2730-7034